EXTENDED VENOUS THROMBOEMBOLISM PROPHYLAXIS WITH RIVAROXABAN DOES NOT INCREASE BLEEDING COMPLICATIONS AFTER MAJOR ABDOMINAL AND PELVIC SURGERY.

被引：0
|
作者：
Kebkalo, A.
Tyselskyi, V.
Reiti, A.
Wong, D.
Poylin, V.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2020年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1096
引用
收藏
页码：E232 / E232
页数：1
相关论文
共 50 条
  • [41] The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients
    ten Cate, Hugo
    Lensing, Anthonie W. A.
    Weitz, Jeffrey I.
    Middeldorp, Saskia
    Beyer-Westendorf, Jan
    Kubitza, Dagmar
    Brighton, Timothey
    Raskob, Gary E.
    Mismetti, Patrick
    Prandoni, Paolo
    Gebel, Martin
    Prins, Martin H.
    THROMBOSIS RESEARCH, 2018, 170 : 75 - 83
  • [42] Limited Benefit to Extended Prophylaxis for Venous Thromboembolism (VTE) After Major Abdominal Oncologic Resection in an Academic Community Cancer Center
    Sheldon, Yarrow
    Johns, Michael
    Gbadebo, Bayo
    Claudine, Jurkovitz
    Caplan, Richard
    Petrelli, Nicholas J.
    Tiesi, Gregory
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 482 - 482
  • [43] Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer, KA
    Eriksson, BI
    Lassen, MR
    Turpie, AGG
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18): : 1305 - 1310
  • [44] Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgery
    Kukreja, Janet E. Baack
    Levey, Helen R.
    Scosyrev, Emil
    Kiernan, Maureen
    Berrondo, Claudia
    McNamee, Carrie
    Wu, Guan
    Joseph, Jean V.
    Ghazi, Ahmed
    Rashid, Hani
    Dozier, Ann
    Messing, Edward M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (09) : 387.e7 - 387.e16
  • [45] Cost-effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in major orthopaedic surgery in Switzerland
    Sendi, P
    Leuppi, JD
    VALUE IN HEALTH, 2004, 7 (06) : 732 - 733
  • [46] The duration of deep vein thrombosis prophylaxis after major abdominal or pelvic surgery
    Bergqvist, David
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (04): : 192 - 193
  • [47] Implementation of a Comprehensive Post-Discharge Venous Thromboembolism Prophylaxis Program for Abdominal and Pelvic Surgery Patients
    Najjar, Peter A.
    Madenci, Arin L.
    Zogg, Cheryl K.
    Schneider, Eric B.
    Dankers, Christian A.
    Pimentel, Marc T.
    Chabria, Amrita S.
    Goldberg, Joel E.
    Sharma, Gaurav
    Piazza, Gregory
    Bleday, Ronald
    Orgill, Dennis P.
    Kachalia, Allen
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (06) : 804 - 813
  • [48] Effectiveness of Standardized Venous Thromboembolism Prophylaxis Order Sets in Patients Undergoing Abdominal or Pelvic Surgery for Cancer
    Mandernach, Molly Weidner
    Lottenberg, Richard
    Johns, Thomas
    Speed, Elaine
    Findlay, Russell L.
    Hou, Wei
    Rajasekhar, Anita
    BLOOD, 2012, 120 (21)
  • [49] XAMOS: A non-interventional study of rivaroxaban in the prophylaxis of venous thromboembolism after hip or knee surgery
    Turpie, A. G. G.
    Jamal, W.
    Schmidt, A.
    Lassen, M.
    Mantovani, L.
    Kreutz, R.
    Haas, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 961 - 961
  • [50] Rivaroxaban A Review of its Use for the Prophylaxis of Venous Thromboembolism after Total Hip or Knee Replacement Surgery
    Duggan, Sean T.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (01) : 57 - 72
12345